Relationship Between <i>MYCN</i> Copy Number and Expression in Rhabdomyosarcomas and Correlation With Adverse Prognosis in the Alveolar Subtype

Daniel Williamson, Yong‐Jie Lu, Tony Gordon, Raf Sciot, Anna Kelsey, Cyril Fisher, Christopher Poremba, John Anderson, Kathy Pritchard‐Jones, Janet Shipley

Journal of Clinical Oncology · 2005 · 126 citations · 24 references

DOIFull text

Open access

Abstract

MYCN deregulation is a feature of rhabdomyosarcoma tumorigenesis, defines groups of patients with a poor prognosis, and is a potential target for novel therapies.

References

24